Diabetic: <130/80 mmHg
Non diabetic: <140/90 mmHg
Statin | eGFR < 60 mL/min/1.73m2 |
---|---|
Lovastatin | Not studied |
Fluvastatin | 80 mg |
Atorvastatin | 20 mg |
Rosuvastatin | 10 mg |
Simvastatin/Ezetmibe | 20 mg/10 mg |
Pravastatin | 40 mg |
Simvastatin | 40 mg |
Recommended doses (mg/d) of statins in adults with CKD
SGLT2i | eGFR < 30 mL/min/1.73m2 | eGFR ≥ 30 and ≤ 60 mL/min 1.73m2 |
---|---|---|
Dapagliflozin |
Do not initiate if GFR < 25; Consult Nephrology.
If already prescribed, may continue 10mg PO daily. Discontinue once on dialysis. |
Approved for use in eGFR ≥ 25.
Dosage for outcome reduction is 10 mg PO daily (non diabetic CKD and/or HFrEF). |
Canagliflozin | Not indicated for persons with CKD and without Diabetes. | |
Empagliflozin | Not indicated for persons with CKD and without Diabetes. |
Statin | eGFR < 60 mL/min/1.73m2 |
---|---|
Lovastatin | Not studied |
Fluvastatin | 80 mg |
Atorvastatin | 20 mg |
Rosuvastatin | 10 mg |
Simvastatin/Ezetmibe | 20 mg/10 mg |
Pravastatin | 40 mg |
Simvastatin | 40 mg |
Recommended doses (mg/d) of statins in adults with CKD
SGLT2i | eGFR < 30 mL/min/1.73m2 | eGFR ≥ 30 mL/min 1.73m2 |
---|---|---|
Canagliflozin |
Do not initiate; Consult Nephrology.
If already prescribed, may continue 100mg PO daily. Discontinue once on dialysis. |
Dosage for outcome reduction start 100 mg PO daily;
may increase up to 300mg PO daily for additional A1C control when GFR > 60. |
Dapagliflozin |
Do not initiate if GFR < 25; Consult Nephrology.
If already prescribed, may continue 10mg PO daily. Discontinue once on dialysis. |
Approved for use in eGFR ≥ 25.
Dosage for outcome reduction is 10 mg PO daily (DKD and/or HFrEF). |
Empagliflozin |
Not indicated for DKD; use alternative agent if initiating therapy but may continue this agent in patient who are already initiated.
May consider: HFrEF Treatment at GFR > 20. Discontinue once on dialysis. |
10 mg OD for Organ protection.
25 mg OD for A1C control. |